Terms: = Thyroid cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Clinical Outcome
131 results:
1. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
[TBL] [Abstract] [Full Text] [Related]
2. BRAF
Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
[TBL] [Abstract] [Full Text] [Related]
3. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract] [Full Text] [Related]
4. The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study.
Zuhur SS; Aggul H; Avci U; Erol S; Tuna MM; Uysal S; Akbaba G; Kilinc F; Catak M; Tekin S; Ozturk BO; Yavuz HC; Kadioglu P; Cinar N; Bayraktaroglu T; Topcu B; Altuntas Y; Elbuken G
Endocrine; 2024 Mar; 83(3):700-707. PubMed ID: 37736822
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of microwave ablation for the treatment of multifocal versus unifocal T1N0M0 papillary thyroid carcinoma: a propensity-matched multicentre retrospective study.
Zhao ZL; Dong G; Wang SR; Liu Y; He JF; Shi LL; Guo JQ; Wang ZH; Cong ZB; Liu LH; Yang BB; Qu CP; Wei Y; Peng LL; Li Y; Lu NC; Wu J; Yu MA
Eur Radiol; 2023 Dec; 33(12):8727-8735. PubMed ID: 37466709
[TBL] [Abstract] [Full Text] [Related]
6. Incidentally detected 18 F-FDG PET-CT-avid thyroid nodules in patients with advanced malignancy: long-term oncological outcomes from a single-centre retrospective cohort.
Owens C; Fitzhugh A; Harrington K; Paleri V; Sharma B; Shur J; Ap Dafydd D
Nucl Med Commun; 2023 Sep; 44(9):810-815. PubMed ID: 37272278
[TBL] [Abstract] [Full Text] [Related]
7. Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis.
Staubitz JI; Müller C; Heymans A; Merten C; Roos B; Poplawski A; Ludt A; Strobl S; Springer E; Schad A; Roth W; Musholt TJ; Hartmann N
BJS Open; 2023 May; 7(3):. PubMed ID: 37146205
[TBL] [Abstract] [Full Text] [Related]
8. Magnetic resonance diagnosis of laryngeal chondritis after transoral laser microsurgery for laryngeal cancer.
Cunha B; Lancini D; Rondi P; Ravanelli M; Maroldi R; Paderno A; Zigliani G; Bertotto I; Piazza C; Farina D
Acta Otorhinolaryngol Ital; 2023 Feb; 43(1):32-41. PubMed ID: 36860148
[TBL] [Abstract] [Full Text] [Related]
9. Do Histologically Aggressive Subtypes of Papillary thyroid Microcarcinoma have Worse clinical outcome than Non-Aggressive Papillary thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study.
Zuhur SS; Aggul H; Avci U; Erol S; Tuna MM; Uysal S; Akbaba G; Kilinç F; Catak M; Tekin S; Bilen OI; Öztürk BO; Erden EB; Elbuken G; Yavuz HC; Kadioglu P; Cinar N; Kutluturk F; Bayraktaroglu T; Topçu B; Arslan AI; Gucer H; Cihangiroglu G; Topal CS; Ozturk T; Tekin L; Artas G; Akcay E; Gun BD; Altuntas Y
Horm Metab Res; 2023 May; 55(5):323-332. PubMed ID: 36764327
[TBL] [Abstract] [Full Text] [Related]
10. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
11. Is multifocality a risk factor in low-risk papillary thyroid cancer?
Sapuppo G; Grasso S; Di Benedetto G; Marturano I; Costanzo G; Belfiore A; Pellegriti G
Endokrynol Pol; 2022; 73(6):928-934. PubMed ID: 36094871
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of Delayed Surgery and clinical outcomes in Intermediate- and High-risk Papillary thyroid cancer.
Zhou H; Wu J; Shi L; Wang Y; Liu B
J Clin Endocrinol Metab; 2022 Nov; 107(12):3389-3397. PubMed ID: 36056633
[TBL] [Abstract] [Full Text] [Related]
13. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
14. Potential Impact of Body Mass Index on the clinical outcome of Papillary thyroid cancer After High-Dose Radioactive Iodine Therapy.
Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of Diagnostic Value of SPECT/CT Imaging in Post-radioiodine Therapy in thyroid cancer.
Al Hatmi A; Jain A; Mittal AK; Hussain S
Sultan Qaboos Univ Med J; 2022 Feb; 22(1):74-81. PubMed ID: 35299812
[TBL] [Abstract] [Full Text] [Related]
16. clinical efficacy of fixed-dose radioactive iodine for the treatment of hyperthyroidism at a single centre: our experience.
Nair D; Maweni R; Constantinou C; Kandiah S; Nagala S; Aung T
Ir J Med Sci; 2022 Aug; 191(4):1659-1665. PubMed ID: 34537910
[TBL] [Abstract] [Full Text] [Related]
17. thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors.
Rodia R; Pani F; Caocci G; La Nasa G; Simula MP; Mulas O; Velluzzi F; Loviselli A; Mariotti S; Boi F
J Endocrinol Invest; 2022 Feb; 45(2):291-300. PubMed ID: 34283388
[TBL] [Abstract] [Full Text] [Related]
18. Five-year follow-up and clinical outcome in euthyroid patients with thyroid nodules.
Bajuk Studen K; Gaberscek S; Pirnat E; Zaletel K
Radiol Oncol; 2021 May; 55(3):317-322. PubMed ID: 34051706
[TBL] [Abstract] [Full Text] [Related]
19. Impact of prior cancer history on survival of patients with gastric cancer.
Wen L; Yu K; Lu H; Zhong G
Eur J Surg Oncol; 2021 Sep; 47(9):2286-2294. PubMed ID: 33632589
[TBL] [Abstract] [Full Text] [Related]
20. Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy.
Luongo C; Morra R; Gambale C; Porcelli T; Sessa F; Matano E; Damiano V; Klain M; Schlumberger M; Salvatore D
J Endocrinol Invest; 2021 Sep; 44(9):1927-1933. PubMed ID: 33576954
[TBL] [Abstract] [Full Text] [Related]
[Next]
